Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

Want AI Adoption to Be Successful? Train the C-Suite First

The prevailing assumption is that executives only need high-level briefings, not practical AI training. That's wrong.